Skip to main content

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Mª Jesús Cruz Carmona

Institutions of which they are part

Head of group
Pneumology
Vall Hebron Institut de Recerca

Projects

Compte intern no vinculat a l'exepedient, ingres de l'ajut en el compte intern 2016-750

IP: Mª Jesús Cruz Carmona
Collaborators: -
Funding agency: SOCIETAT CATALANA DE PNEUMOLOGIA
Funding: 14400
Reference: SOCAP_2019_ROMERO
Duration: 01/09/2019 - 31/08/2020

Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome (EXIMIOUS)

IP: Mª Jesús Cruz Carmona
Collaborators: Fco. Javier Muñoz Gall, David Espejo Castellanos, David Soler Segovia, Ana Villar Gomez
Funding agency: EUROPEAN COMMISSION
Funding: 395500
Reference: EXIMIOUS_H2020_SC1-BHC-2019
Duration: 01/01/2020 - 31/12/2024

Estudio de los mecanismos de progresión a fibriosis pulmonar en pacientres con neumonitis por hipersensibilidad.

IP: Mª Jesús Cruz Carmona
Collaborators: Iñigo Ojanguren Arranz
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI18/00345
Duration: 01/01/2019 - 30/06/2023

Grup de Recerca de Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2017SGR0434
Duration: 01/01/2017 - 30/09/2021

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Marc Martí Gallostra

Marc Martí Gallostra

Main researcher
General Surgery
Read more
Deborah Pareto Onghena

Deborah Pareto Onghena

Main researcher
Neuroradiology
Read more
Mª Dolores Braquehais Conesa

Mª Dolores Braquehais Conesa

Main researcher
Psychiatry, Mental Health and Addictions
Read more
Lucas Rivera Sánchez

Lucas Rivera Sánchez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.